NYSE:NGVT - Ingevity Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $88.31 +2.12 (+2.46 %) (As of 01/16/2019 04:00 PM ET)Previous Close$86.19Today's Range$86.54 - $88.6552-Week Range$66.57 - $106.59Volume164,200 shsAverage Volume162,818 shsMarket Capitalization$3.62 billionP/E Ratio34.23Dividend YieldN/ABeta1.62 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells wood-based chemically activated carbon products primarily for gasoline vapor emission control systems. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment develops, manufactures, and sells a range of specialty chemicals derived from co-products of the Kraft pulping process. This segment's products are used in various applications comprising asphalt paving, oilfield exploration and production, printing inks, adhesives, agrochemical dispersants, lubricants, and other diverse industries. Ingevity Corporation was incorporated in 2015 and is headquartered in North Charleston, South Carolina. Receive NGVT News and Ratings via Email Sign-up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:NGVT Previous SymbolNASDAQ:NGVT CUSIPN/A Webwww.ingevity.com Phone843-740-2300Debt Debt-to-Equity Ratio2.31 Current Ratio2.34 Quick Ratio1.26Price-To-Earnings Trailing P/E Ratio34.23 Forward P/E Ratio22.94 P/E Growth1.54 Sales & Book Value Annual Sales$972.40 million Price / Sales3.81 Cash Flow$3.6537 per share Price / Cash Flow24.17 Book Value$6.60 per share Price / Book13.38Profitability EPS (Most Recent Fiscal Year)$2.58 Net Income$126.50 million Net Margins15.53% Return on Equity47.45% Return on Assets12.51%Miscellaneous Employees1,500 Outstanding Shares41,970,000Market Cap$3.62 billion OptionableOptionable Ingevity (NYSE:NGVT) Frequently Asked Questions What is Ingevity's stock symbol? Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT." How were Ingevity's earnings last quarter? Ingevity Corp (NYSE:NGVT) issued its earnings results on Wednesday, October, 24th. The company reported $1.16 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.04 by $0.12. The business had revenue of $311.20 million for the quarter, compared to analyst estimates of $305.50 million. Ingevity had a net margin of 15.53% and a return on equity of 47.45%. View Ingevity's Earnings History. When is Ingevity's next earnings date? Ingevity is scheduled to release their next quarterly earnings announcement on Tuesday, February 19th 2019. View Earnings Estimates for Ingevity. What price target have analysts set for NGVT? 8 brokers have issued 12-month target prices for Ingevity's shares. Their predictions range from $68.00 to $110.00. On average, they anticipate Ingevity's stock price to reach $96.1250 in the next year. This suggests a possible upside of 8.8% from the stock's current price. View Analyst Price Targets for Ingevity. What is the consensus analysts' recommendation for Ingevity? 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ingevity. Has Ingevity been receiving favorable news coverage? News headlines about NGVT stock have trended somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ingevity earned a news sentiment score of -1.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days. Who are some of Ingevity's key competitors? Some companies that are related to Ingevity include FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), KURARAY CO LTD/ADR (KURRY), Huntsman (HUN), Ashland Global (ASH), W. R. Grace & Co (GRA), Olin (OLN), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), Innospec (IOSP), KMG Chemicals (KMG) and Nexeo Solutions (NXEO). Who are Ingevity's key executives? Ingevity's management team includes the folowing people: Mr. D. Michael Wilson, Pres, CEO & Director (Age 55)Mr. John C. Fortson, Exec. VP, CFO & Treasurer (Age 51)Ms. Katherine Pryor Burgeson, Exec. VP, Gen. Counsel & Sec. (Age 60)Mr. Stuart Edward Woodcock Jr., Exec. VP & Pres of Performance Materials (Age 52)Mr. Michael P. Smith, Exec. VP and Pres of Performance Chemicals, Strategy & Bus. Devel. (Age 57) Who are Ingevity's major shareholders? Ingevity's stock is owned by many different of institutional and retail investors. Top institutional investors include Copper Rock Capital Partners LLC (0.71%), Louisiana State Employees Retirement System (0.04%), Boston Advisors LLC (0.03%), Fruth Investment Management (0.02%) and First Midwest Bank Trust Division (0.01%). View Institutional Ownership Trends for Ingevity. Which institutional investors are selling Ingevity stock? NGVT stock was sold by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Louisiana State Employees Retirement System, Boston Advisors LLC and First Midwest Bank Trust Division. View Insider Buying and Selling for Ingevity. Which institutional investors are buying Ingevity stock? NGVT stock was bought by a variety of institutional investors in the last quarter, including Fruth Investment Management. View Insider Buying and Selling for Ingevity. How do I buy shares of Ingevity? Shares of NGVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Ingevity's stock price today? One share of NGVT stock can currently be purchased for approximately $88.31. How big of a company is Ingevity? Ingevity has a market capitalization of $3.62 billion and generates $972.40 million in revenue each year. The company earns $126.50 million in net income (profit) each year or $2.58 on an earnings per share basis. Ingevity employs 1,500 workers across the globe. What is Ingevity's official website? The official website for Ingevity is http://www.ingevity.com. How can I contact Ingevity? Ingevity's mailing address is 5255 VIRGINIA AVENUE, NORTH CHARLESTON SC, 29406. The company can be reached via phone at 843-740-2300 or via email at [email protected] MarketBeat Community Rating for Ingevity (NYSE NGVT)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 233 (Vote Outperform)Underperform Votes: 216 (Vote Underperform)Total Votes: 449MarketBeat's community ratings are surveys of what our community members think about Ingevity and other stocks. Vote "Outperform" if you believe NGVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NGVT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/16/2019 by MarketBeat.com StaffFeatured Article: What is the yield curve?